Evidence map›Paper›PMID 32568216›Full record

ArticleThe Journal of clinical investigation2020

Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.

Catherine R Cochrane, Vijesh Vaghjiani, Anette Szczepny, W Samantha N Jayasekara, Alvaro Gonzalez-Rajal, Kazu Kikuchi, Geoffrey W McCaughan, Andrew Burgess, Daniel J Gough, D Neil Watkins and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. The Five-Decade Journey of Small Cell Lung Cancer.Cancer communications (London, England) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Catherine R CochraneHudson Institute of Medical Research, Clayton, Victoria, Australia.
Vijesh VaghjianiHudson Institute of Medical Research, Clayton, Victoria, Australia.
Anette SzczepnyHudson Institute of Medical Research, Clayton, Victoria, Australia.
W Samantha N JayasekaraHudson Institute of Medical Research, Clayton, Victoria, Australia.
Alvaro Gonzalez-RajalKinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Kazu KikuchiDevelopmental and Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.
Geoffrey W McCaughanSydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Andrew BurgessANZAC Research Institute, Concord, New South Wales, Australia.
Daniel J GoughHudson Institute of Medical Research, Clayton, Victoria, Australia.
D Neil WatkinsResearch Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
Jason E CainHudson Institute of Medical Research, Clayton, Victoria, Australia.
Hudson Institute of Medical Research · AUThe University of Sydney · AUCancerCare Manitoba · CAGarvan Institute of Medical Research · AUVictor Chang Cardiac Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ligand-dependent activation of Hedgehog (Hh) signaling in cancer occurs without mutations in canonical pathway genes. Consequently, the genetic basis of Hh pathway activation in adult solid tumors, such as small-cell lung cancer (SCLC), is unknown. Here we show that combined inactivation of Trp53 and Rb1, a defining genetic feature of SCLC, leads to hypersensitivity to Hh ligand in vitro, and during neural tube development in vivo. This response is associated with the aberrant formation of primary cilia, an organelle essential for canonical Hh signaling through smoothened, a transmembrane protein targeted by small-molecule Hh inhibitors. We further show that loss of both Trp53 and Rb1 disables transcription of genes in the autophagic machinery necessary for the degradation of primary cilia. In turn, we also demonstrate a requirement for Kif3a, a gene essential for the formation of primary cilia, in a mouse model of SCLC induced by conditional deletion of both Trp53 and Rb1 in the adult airway. Our results provide a mechanistic framework for therapeutic targeting of ligand-dependent Hh signaling in human cancers with somatic mutations in both TP53 and RB1.

Indexed as

AutophagySignal TransductionTranscription, GeneticAnimalsHedgehog ProteinsHumansLung NeoplasmsMiceMice, TransgenicMutationNeoplasms, ExperimentalRetinoblastoma Binding ProteinsSmall Cell Lung CarcinomaTumor Suppressor Protein p53Hedgehog ProteinsRb1 protein, mouseRetinoblastoma Binding ProteinsTrp53 protein, mouseTumor Suppressor Protein p53AutophagyCell BiologyLung cancerOncology

Identifiers

PMID32568216
PMCPMC7410056
OpenAlexW3036458210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.